The Trifecta of Polo-Like Kinases, Cancer, and the Immune System: Emerging Intersections and Therapeutic Insights

Molecular Cancer Research · Published 2026-03-23 · DOI 10.1158/1541-7786.mcr-25-1138

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1158/1541-7786.mcr-25-1138

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer · Molecular Cancer Research · 2026 · Same journal
• The PON1-NDUFA4 axis maintains mitochondrial respiratory fitness and drives lenvatinib tolerance in hepatocellular carcinoma · Molecular Cancer Research · 2026 · Same journal
• Selected Articles from This Issue · Molecular Cancer Research · 2026 · Same journal
• C1QBP–STAT1 Interaction Promotes Activation of the c-Myc–CHK1/CHK2 Signaling Axis and Radioresistance in Lung Cancer · Molecular Cancer Research · 2026 · Same journal
• Selected Articles from This Issue · Molecular Cancer Research · 2026 · Same journal
• MYC-Mediated USP39 Upregulation Stabilizes SRSF1 in Pancreatic Cancer · Molecular Cancer Research · 2026 · Same journal
• Comprehensive Multi-Omic Profiling of Desmoplastic Small Round Cell Tumors Identifies Targetable Pathways with Therapeutic Opportunities · Molecular Cancer Research · 2026 · Same journal
• Genetically Engineered Human iPS Cell-Derived Kidney Organoid Recapitulates an Early Stage of ALK Fusion Gene-Associated Renal Tumorigenesis · Molecular Cancer Research · 2025 · Same journal
• SF3B4-QKI Splicing Complex Generates Circ-FNDC3B and Mediates Breast Cancer Inhibition · Molecular Cancer Research · 2026 · Same journal
• 3beta-HSD1-mediated steroid back-conversion maintains androgen signaling in prostate cancer · Molecular Cancer Research · 2026 · Same journal